ATS Life Sciences provides automated manufacturing solutions for the assembly and handling of a broad range of medical and pharmaceutical products.

ATS Life Sciences

inTEST Corporation supplies test and process solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through two segments, Thermal Products (Thermal) and Electromechanical Semiconductor Products (EMS). The Thermal segment offers ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; Thermal Chambers; Thermal Platforms; Thermonics temperature conditioning products that provide tempered gas or fluid; ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions; EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The EMS segment provides in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly or the handler's test socket. This segment also offers tester interfaces that provide electrical connections between the tester and the wafer prober or integrated circuit (IC) handler; and scorpion flying probe test systems, which designs and manufactures robotics-based electronic test equipment, as well as provides application support services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.

inTEST Corporation

Sherpa GX offers bespoke travel experiences and scheduled expeditions, focusing on wildlife encounters and immersive cultural experiences in remote destinations.

Metric
Company Name	ATS Life Sciences	inTEST Corporation	Sherpa GX
Symbol		INTT
MSH ID	COM:ATSLIFESCIENCES	COM:INTEST	COM:SHERPAGX
Market	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Technology	Consumer Services
Industry	Medical Devices and Equipment	Semiconductors	Travel and Tourism
Country	US	US	US
Stage
Employee Count		323
Website	atslifesciences.com	intest.com	sherpagx.com
LinkedIn
Founders

Metric
Market Cap		136.89M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		123.30M
Revenue (LTM)
Revenue (NTM)
Gross Profit		56.98M
EBITDA		15.12M
Operating Income		10.44M
Net Income		9.34M
EPS		0.82
Diluted EPS		0.79
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.47
Operating Profit Margin		0.11
EBITDA Margin		0.12
Net Profit Margin		0.09
Return on Equity		0.15
Return on Assets		0.09
Return on Capital Employed		0.13

COM:ATSLIFESCIENCES

ATS Life Sciences

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		11.57
P/B Ratio		1.45
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		1.20
EV Multiple		11.70

Metric
Days Sales Outstanding		58.35
Days Payables Outstanding		38.51
Days Inventory Outstanding		172.73
Operating Cycle		241.57
Cash Conversion Cycle		196.97
Asset Turnover		0.96

Metric
Operating Cash Flow		16.20M
Free Cash Flow		14.91M
Cash Flow to Debt		1.16
Operating Cash Flow/Sales		0.13
Free Cash Flow Yield		0.09

Metric
Cash & Equivalents		45.26M
Accounts Receivable		2.99M
Inventory		20.09M
Goodwill		21.73M
Debt to Capitalization		0.21
Debt to Assets		0.14
Current Ratio		3.30
Quick Ratio		2.61

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.02
R&D to Revenue		0.06
SG&A to Revenue		0.16